CORC  > 西安交通大学
LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.
Ding Chenguang; Han Feng; Xiang Heli; Xia Xinxin; Wang Yuxiang; Dou Meng; Zheng Jin; Li Yang; Xue Wujun; Ding Xiaoming
刊名Journal of cellular biochemistry
2018
卷号119页码:10406-10414
关键词renal carcinoma colorectal neoplasia differentially expressed (CRNDE) metastasis biomarker
ISSN号1097-4644
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2917917
专题西安交通大学
推荐引用方式
GB/T 7714
Ding Chenguang,Han Feng,Xiang Heli,et al. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.[J]. Journal of cellular biochemistry,2018,119:10406-10414.
APA Ding Chenguang.,Han Feng.,Xiang Heli.,Xia Xinxin.,Wang Yuxiang.,...&Tian Puxun.(2018).LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma..Journal of cellular biochemistry,119,10406-10414.
MLA Ding Chenguang,et al."LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.".Journal of cellular biochemistry 119(2018):10406-10414.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace